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A B S T R A C T
The use of plant-based feeds warrants the supplementation with selenium (Se) to cover the requirement for
Atlantic salmon. Depending on its chemical form, Se is a trace element with a narrow range between require-
ment and toxicity for most vertebrates. Information on safe upper limit for Atlantic salmon feed supplementation
is lacking. Atlantic salmon (147 g) were fed a low natural background organic Se diet (0.45 mg Se kg−1, wet
weight (ww)) fortified with 5 graded levels of inorganic sodium selenite (0.45, 5.4, 11.0, 29.4, or 60.0 mg kg−1
ww) or organic selenomethionine (SeMet) (0.45, 6.2, 16.2, 21, or 39mg kg−1 ww), in triplicate for 3months.
Excess Se supplementation was assessed by targeted biomarkers of Se toxicity pathways (e.g. markers of oxi-
dative stress and lipid metabolism), as well as general adverse effect parameters (plasma biochemistry, hema-
tology, liver histopathology, and growth). Safe limits were set by model-fitting the effect data in a dose-response
(lower bound) bench mark dose (BMDL) evaluation. Fish fed the two highest selenite levels showed mortality
while fish fed SeMet had no mortality. Fish fed 5.4–11mg selenite kg−1 feed showed significantly (ANOVA,
Tukey's t-test, p < .05) increased liver oxidative stress, as seen from altered hepatic GSH and vitamin E levels,
and liver damage as seen from increased plasma ALAT and liver histopathology such as degeneration and focal
necrosis. Fish fed SeMet mainly showed liver pathology and kidney dysfunction as seen from altered plasma
creatinine and total plasma proteins in fish fed ≥21mg kg−1, compared to control. For selenite exposed fish, a
safe feed limit (BMDL) was set at 1–2mg kg−1 ww feed (daily dose 0.01–0.02mg kg BW−1 day−1), based on
plasma ALAT increase, liver vitamin E depletion, and liver histopathology. For SeMet fed fish, the safe feed limit
was higher than for selenite with a BMDL of 2.8 mg kg−1 ww (dose 0.03mg kg BW−1 day−1), based on liver
histopathology and plasma creatinine. In conclusion, with regards to fish health, Atlantic salmon seemed to
tolerate the supplementation of selenite or SeMet to a level of total selenium of respectively 1–2 or 3mg kg−1
feed, respectively, in a high plant-based salmon feed with background levels of 0.45mg Se kg−1.
1. Introduction
Due to a rapid growth in aquaculture and limited access to marine
resources, fish oil and fish meal in feeds to carnivorous marine fish
species such as Atlantic salmon (Salmo salar) have been replaced with
plant ingredients the last decades (Ytrestoyl et al. 2015). The change
from marine to plant feed ingredients will alter the nutritional com-
position of salmon feeds, reducing the levels of essential micro-nu-
trients that are naturally high in fish meal and oil such as vitamins and
minerals (Sissener et al. 2013). Selenium (Se) is one of the essential
minerals that is known to be higher in fish meal than plant ingredients
(Betancor et al. 2016), although plant products can differ largely in Se
content according to the Se concentrations in soil (Alfthan et al. 2015).
The observed Se decline in Norwegian produced commercial salmon
feed during the last decade has been attributed to the decreased use of
fish meal (Sissener et al. 2013). Furthermore, the use of plant in-
gredients may reduce the bioavailability of minerals due to presence of
phytates (Denstadli et al. 2006). Selenium concentration in Atlantic
salmon flesh was lower when fed on plant protein replacement feeds
compared to marine protein feeds (Betancor et al. 2016). Several stu-
dies have indicated the need for Se supplementation in plant-based feed
to marine carnivorous fish (Fontagne-Dicharry et al. 2015; Godin et al.
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2015; Pacitti et al. 2015; Ilham et al., 2016). Of the mineral supple-
ments used, the organic forms, seleno-methionine (SeMet) or Se-yeast
forms have a higher bioavailability than inorganic selenite forms (Rider
et al. 2009; Fontagne-Dicharry et al. 2015). Studies in Atlantic salmon
indicate that the natural Se levels in plant based diets cover require-
ment (Hamre et al. 2016). Higher Se requirements, and hence need for
possible supplementation, might occur during the early life stages of
fish (Bell et al. 1985) or during handling stress (Rider et al. 2009). In
the EU, feeds can be supplemented with organic (e.g. selenized yeasts)
Se to a maximum authorised level of 0·2 mg kg−1 (Regulations (EU) No
427/2013; 445/2013; 121/2014; 847/2014 and 2015/489). The max-
imum limit for total Se in animal feeds, including fish feed, has been set
at 0.5mg kg−1 feed ((EC) No 1831/2003 and amendments).
Selenium has a narrow range between its toxic and its beneficial
effects (Wang and Lovell 1997; Teh et al. 2004; Han et al. 2011; Lee
et al. 2016). Supplementation of aquafeeds with SeMet or selenite
hence requires toxicological assessment to set safe upper limits that
protect fish health (Berntssen et al. 2017). Several studies have given an
overview on adverse effect levels in several fish species exposed to both
excess dietary inorganic and organic Se (Lemly 1993a; Hamilton 2004;
Zee et al. 2016a). A wide range of effect concentrations have been re-
ported that differ between fish species and life stages, hence species-
specific adverse effects of Se supplementation is important to consider.
Several studies have performed graded dose-response with organic or
inorganic Se for salmonids, including chinook salmon (Oncorhynchus
tshawytscha) (Hamilton et al., 1990), cutthroat trout (Oncorhynchus
clarkii) (Hardy et al. 2010), and rainbow trout (Oncorhynchus mykiss)
(Hilton et al. 1980; Hamilton et al. 1990; Hamilton 2004; Palace et al.
2004; Rider et al. 2009; Hunt et al. 2011; Wiseman et al. 2011a;
Wiseman et al. 2011b; Knight et al. 2016; Pacitti et al. 2016b). How-
ever, few studies have assessed selenite and SeMet supplementation in
Atlantic salmon (Lorentzen et al. 1994; Berntssen et al. 2017), which is
one of the main farmed salmonid species.
Oxidative stress has been identified as a main toxic action (MOA) for
excess dietary Se exposures (Palace et al. 2004; Miller et al. 2007; Han
et al. 2010; Choi et al. 2015; Hursky and Pietrock 2015; Lee et al. 2015;
Hauser-Davis et al. 2016). Also for dietary Se exposed Atlantic salmon,
oxidative stress was a main driver for both high selenite and SeMet-
yeast toxicity, with a higher toxicity for selenite compared to SeMet-
yeast (Berntssen et al. 2017). In contrast, for white sturgeon (Acipenser
transmontanus) (Zee et al. 2016a; Zee et al. 2016b) oxidative stress was
not the main cause of dietary SeMet toxicity, and juvenile rainbow trout
fed organic Se showed no oxidative stress while growth and liver lipids
were reduced (Knight et al. 2016). Recent wide-scope pathway assess-
ments, by use of metabolomics, have shown that disturbance in lipid
metabolism could be an additional MOA for inorganic and organic Se
toxicity (Berntssen et al. 2017). Earlier wide-scope pathway assess-
ments by transcriptomics confirmed that disturbed liver lipid synthesis
and metabolism was a central mechanism in dietary organic Se exposed
rainbow trout (Knight et al. 2016; Pacitti et al. 2016a).
Assessment of biochemical markers in the central pathways of
dietary selenite and SeMet toxicity can be used to assess early effects of
excess selenite and SeMet exposures. Atlantic salmon fed sublethal se-
lenite and SeMet levels (15mg kg−1), showed reduced vitamin E, for-
mation of peroxidative products, and reduction in glutathione as mar-
kers of oxidative stress, while altered lipid composition were used as
markers of disturbed lipid metabolism (Berntssen et al. 2017). The use
of biomarkers in central pathways of toxicity, are valuable in sub-
chronic studies (10% of life cycle) where chronic whole-body adverse
effects are expected to occur only after prolonged (life-cycle) exposure.
Final adverse effect outcomes of dietary selenite and SeMet in fish,
include decreased egg viability (Schultz and Hermanutz 1990), reduced
neurological and immunological functions (Choi et al. 2015), reduced
growth (De Riu et al. 2014; Zee et al. 2016a; Berntssen et al. 2017),
reducedenergy stores (De Riu et al. 2014; Zee et al. 2016a), patholo-
gical effects on kidney and liver (Hicks et al. 1984; Teh et al. 2004;
Tashjian et al. 2006; Zee et al. 2016a), pathological effects on heart and
ovaries, as well as skeleton/cranial deformation (Lemly, 2002;
Hamilton, 2003; Hamilton, 2004).
Traditionally, animal health safe dietary levels of feed supplements
in toxicological studies are assessed by establishing a no observed ad-
verse effect level (NOAEL) based on a (sub)-chronic dose-response
study with graded levels of the supplement (Teh et al. 2004). The
European food safety agency (EFSA), recently evaluated the methods to
assess safe feed levels, and advised to use bench mark dose (BMD)
models instead of NOAEL to establish safe levels of supplements or
contaminants (EFSA 2017b). In addition, a guidance document was
published in which the difference between adverse effect, biomarkers of
exposure or effect, and mode of action (MOA) were defined (EFSA
2017a). In general, dose-response adverse effects (i.e. reduced growth,
histopathology) are weighed in the BMD with a benchmark response
(BMR) of 5%, while for biomarker of effect or exposure (i.e. plasma
enzymes and organ oxidative stress) a higher (20%) BMR is used. For
histopathology data (i.e. degeneration and focal necrosis) a BMR of
10% is used with an extra risk factor assessment (EFSA 2017b). The
present study assessed the safe limits of selenite and SeMet supple-
mentation to plant based feed with regards to the health of Atlantic
salmon. The present paper uses an integrated feed safety assessment on
several levels of biological organization. These include the use of spe-
cific targeted biomarkers of Se toxicity mode of action (e.g. markers of
oxidative stress and lipid metabolism) as well as general adverse effect
parameters (plasma biochemistry, hematology, histopathology, and
growth) of Se toxicity. The safe levels are assessed in a common EFSA
dose-response bench mark dose regression model applied to all para-
meters.
2. Material and methods
2.1. Ethic statement
The experiment was approved by the Norwegian National Animal
Research Authority (Mattilsynet; FOTS ID: 9003) and performed in
compliance with national and international ethical standards.
2.2. Experimental conditions
The feeding trial was carried out at NOFIMA (Sunndalsøra, Norway)
between the 15th of November 2016 and the 3th of March 2017. A total
of 1890 Atlantic salmon smolt (Salmo salar, L., Salmobreed, 6months,
both genders) were randomly distributed into 27 tanks (1.4 m2 and ca
840 L volume) with 70 fish in each tank with an initial weight of
147 ± 4 g (mean ± SD, n=30). Prior to the experiment, all fish were
fed a control diet (see diet description under) during a 2-week accli-
mation to holding facilities. Thereafter, randomly selected tanks re-
ceived one of nine experimental diets for 3months, in triplicate. The
feeding regime was based on automatic feeders under a photoperiod
regime with 24 h light. Six daily meals were provided with 4 h between
the meals, to a level approximating 1% of body weight per day. The
feeding rate was adjusted for growth biomass increase, which was as-
sessed by measured average weight gain of the sampled fish per sam-
pling point. Fish were routinely monitored for nutritional performance
and appetite throughout the experiment. Unconsumed feed pellets were
collected and weighed once per day, and feed intake, feed conversion
and Se exposure were calculated. To avoid possible leakage from feces
or pellets to the water, a relative high water flow-through was main-
tained of 11 Lmin−1 per tank. Water Se levels were monitored by
routine water samples of 50ml, which were taken from each tank and
acidified with nitric acid 65% HNO3 (Suprapur, Merck, Germany) in a
final concentration of 5.2% for Se analysis. Environmental parameters
in tanks were measured five times a week, showing a salinity of
27 ± 0.3‰, temperature of 8.0 ± 0.3 °C, and oxygen levels of
85 ± 4% at the outlet.
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Five fish per tank (n=15 per dietary group) were sampled at
90 days of exposure for tissue sampling. Fish were randomly collected
from the tanks, anesthetized in a bath of tricaine methanesulfonate
(FINQUEL MS-222; ~ 60mg L−1). The fish were sacrificed by a blow to
the head and blood samples were taken from the caudal vein quickly
following the initial anesthetization, using a heparinized VACUETTEⓇ
blood collection tube with 21G × 1′ needle. Whole blood was divided
into two aliquots, one of which was used for immediate on-site analyses
of hematocrit and the other aliquot (∼200mL) was kept on ice for
erythrocyte count and hemoglobin determination, which were per-
formed within two days after sampling. For plasma samples, the re-
maining whole blood was centrifuged at 3500g for 10min, and the
plasma was snap-frozen in liquid nitrogen and stored at −80 °C until
further analysis (see below). Body weight and length of each fish was
recorded, and liver, heart and spleen sampled and weighed. Liver
samples were divided into three parts (for analyses of Se content, oxi-
dative stress as tocopherol and TBARS, and glutathione, see sections
under) and immediately frozen in liquid nitrogen followed by storage at
−80 °C until biochemical analyses. In addition, a liver section was
taken for histological assessment of the first 3 sampled fish per tank (see
under). Liver, heart and spleen of the five sampled fish per tank was
weighed as well to assess further organ indexes. Lengths and weight of
the remaining fish at the end of the trial were recorded.
2.3. Experimental diets
Selenium was added as part of the mineral premixture to the basal
diets with low natural Se content. The experimental feeds were pro-
duced by Biomar (Brande, Denmark), and were formulated based on
commercial diets that fulfilled the nutritional requirements of salmo-
nids (NRC 2011), using standard commercially available feed materials.
The general basal diet had the following composition: fish meal (10%),
soya protein concentrate (SPC; 10%), wheat gluten (17%), maize gluten
(10%), pea protein 50 (5%), pea protein> 72 (5%), wheat (10.5%),
fish oil (12.2%), rape seed oil (12.2%) and micro-nutrient mixture
(8.1%).
Care was taken to select ingredients with low levels of Se, as levels
in plant material can vary depending on the soil (Alfthan et al. 2015),
and a relative low fish meal inclusion was used as this is the main
source of Se in salmon diets. The basal diets were supplemented with
either inorganic Se (sodium selenite, Na2SeO3, DSM, Heerlen, Nether-
land) or organic Se (> 98% L-selenomethionine (Excential Se4000
Minsups, Winsford England) at a nominal concentration of 0, 5, 15, 25
and 50mg kg−1. The inorganic and organic Se levels were chosen to
give a dose-response gradient (see bench mark dose description below),
that was expected to provoke mild sub lethal biomarker effects of in-
organic and organic Se (1–5mg kg−1 (Berntssen et al. 2017)), more
severe chronic sub-lethal toxicity for organic Se (~20mg kg−1 dry
weight (dw) organic Se as Se-yeast fed worms or 15mg kg−1 SeMet ww,
Knight et al. (2016) and Berntssen et al. (2017), respectively) or in-
organic Se (~9mg kg−1 (Hamilton 2004) and 15mg kg−1 (Berntssen
et al. 2017)), and sever chronic toxicity (positive control) (> 20 SeMet
mg kg−1 (Hardy et al. 2010),> 15mg selenite kg−1 (Berntssen et al.
2017)). The analysed Se level in the basal diet was
0.45 ± 0.04mg kg−1 (control), 5.4 ± 0.09 or 6.2 ± 0.2 (low),
11.0 ± 0.3 or 16.2 ± 0.3 (low-medium), 29.4 ± 0.9 or 21 ± 0.3
(medium), 60.0 ± 2 or 39 ± 0.4 (high) mg kg−1 for respectively the
inorganic Se and organic Se supplemented diets (n=3, mean ± SD).
2.4. Se analyses
Diets and tissues of fish were digested using the microwave-acid
decomposition method based on the method described by Berntssen
et al. (2017), modified after Julshamn et al. (2007). Briefly, samples
(0.20–0.25 g) were digested by adding 0.5 mL deionized water (Milli-Q,
Merck Millipore, Oslo, Norway) and 2mL concentrated nitric acid
(HNO3, Fluka, Sigma-Aldrich, Oslo, Norway) in digestion vessels
(Milestone Srl, Sorisole, BG, Italy). The capped vessels were ultra-
waved (UW, SRC, Milestone, Shelton, CT, USA, gas pressure 40 bar and
the temperature increased incrementally to 260 °C) in a container with
30mL Milli-Q water and 5mL hydrogen peroxide (H2O2, Emsure ACS,
ISO, 32% w/w; VWR, Oslo, Norway). Total Se concentration was de-
termined by ICP-MS (iCAP-Q and FAST SC-4Q DX auto sampler, both
Thermo Fisher Scientific Inc., Waltham, Massachusetts, USA). An ex-
ternal calibration curve was made from freshly prepared multi element
standard diluted to appropriate concentrations by 5% (v/v) HNO3. In-
ternal standard (Ge, Rh and Tm, Thermo Fisher Scientific Inc) was use
for correction of instrumental drift during the analysis. Plasma power
was set to 1550W, carrier/nebulizer gas flow to 1.05 Lmin−1, the
plasma/auxilliary gas flow to 0.8 Lmin−1, and He gas (CCT1) flow was
4.6 mL/min. Isotope 78Se was monitored, and the integration time was
0.1 s. Oyster Tissue (OT, CRM 1566 b, National Institute of Standards
and Technology, Gaithersburg, MD, USA) and Lobster Hepatopancreas
(TORT-3, National Research Council Canada, NRC, Ontario, Canada)
were used as reference materials for the analysis.
2.5. Liver redox-homeostasis
Earlier wide-scope metabolic screening of Atlantic salmon fed in-
organic and organic Se showed liver oxidative stress as one of the main
modes of toxic actions (Berntssen et al. 2017). In order to assess liver
oxidative stress, reduced and oxidized glutathione (GSH and GSSG,
respectively), the fat soluble antioxidant vitamin E, and the lipid per-
oxidative products were analysed for individual sampled fish. For GSH
and GSSG, frozen liver tissue samples were weighed and homogenized
in either 4× volume of ice-cold 0.9% saline buffer (9 g L−1 NaCl in
ddH2O) for GSH analyses, or 2× volume of ice-cold thiol scavenger (N-
ethylmaleimide pyridine derivative solution, Cat. No. GT35c; Oxford
Biomedical Research, MI, USA) diluted 3:7 in 0.9% saline buffer for
GSSG analyses, using a ball mill (25 rpm for 1–2min; Retsch MM301
ball mill, Haan, Germany). The homogenates were then centrifuged
(5min, 1500 g, 4 °C), and the supernatant was transferred to new tubes.
The samples were further prepared using the Cuvette Assay kit for GSH/
GSSG (Cat. No. GT35; Oxford Biomedical Research, MI, USA) following
the manufacturer's instructions, and GSH and GSSG were analysed
spectrophotometrically for absorbance at 405 nm in a Wallac VICTOR
(TM) ×5 2030 Multilabel Reader (PerkinElmer Life Sciences, MA,
USA).
Vitamin E was analysed as α-, β-, γ- and δ-tocopherol isomers and
α-, β-, γ- and δ- tocotrienol by high performance liquid chromatography
(HPLC) according to the method described by Hamre et al. (2010). In
short, the homogenized liver samples were saponified (20min at
100 °C) using ethanol, potassium hydroxide, pyrogallol, ascorbic acid
and EDTA, before the samples were extracted three times with hexane.
The solvent was subsequently evaporated under nitrogen and the
samples were diluted with a standard volume of hexane before injection
into the HPLC and detection by fluorescence detector.
Lipid peroxidative products were analysed as thiobarbituric acid-
reactive substances (TBARS) and were determined by the method de-
scribed by Hamre et al. (2010). Using Bligh and Dyer extraction, fat and
water-soluble components in the liver samples were separated, and the
aldehydes were extracted from the sample in the methanol:water phase.
Thiobarbituric acid (TBA) were added in excess to an aliquot of the
methanol:water phase and then heated to form a colored complex be-
tween aldehydes in the sample and TBA. The absorption was measured
at 532 nm, and the concentration of TBARS were quantified using a
standard curve.
2.6. Lipid classes
Earlier wide-scope metabolic screening of Atlantic salmon fed in-
organic and organic Se also showed altered lipid metabolism as one of
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the main modes of toxic actions (Berntssen et al. 2017). Lipids from
pooled liver samples (five fish per tank, hence N=3 per diet) were
extracted in a mixture of chloroform–methanol 2:1 (Merck) with 1%
2,6-di-tert-butyl-4-methylphenol (Sigma-Aldrich) as described by
Torstensen et al. (2004). Briefly, chloroform:methanol (at approxi-
mately twenty times the weight of the sample) was added to the sam-
ples and lipids extracted overnight at −20 °C. Quantification of lipid
class composition was carried out by HPTLC as described by Torstensen
et al. (2011). Lipid classes were quantified by scanning densitometry
using a CAMAG TLC Scanner 3 and calculated using an integrator
(WinCATS-Planar Chromatography, version 1.2.0; CAMAG, Berlin,
Germany). Quantitative determination (mg lipid class/g tissue) of lipid
classes was performed by establishing standard equations for each lipid
class within a linear area, in addition to including a standard mixture of
all the lipid classes at each high-performance TLC plate for corrections
between plate variations. After the extraction of lipids as described
above, neutral lipids (NLs) and polar lipids (PLs) were separated and an
aliquot of 10mg lipids (solved in 200 μL chloroform) was applied to a
solid-phase extraction column (Isolute; Biotage). NLs were eluted with
10mL chloroform–methanol (98:2, v/v) and PLs were eluted with
20mL methanol. For analysis of FAs, the two lipid extracts were filtered
and the remaining samples were saponified and methylated using 12%
boron trifluoride (BF3) in methanol. FA composition was analysed
where the methyl esters were separated using a Trace gas chromato-
graph 2000 (Fison, Elmer, USA) equipped with a 50-m CP-sil 88
(Chromopack) fused silica capillary column (id: 0.32mm) (Lie and
Lambertsen 1991; Torstensen et al. 2004). The FAs were identified by
retention time using standard mixtures of methylesters (Nu-Chek,
Elyian, USA), and the FA composition (area %) was determined. All
samples were integrated using the software Chromeleon® version 6.8
connected to the Gas liquid chromatography (GLC). Amount of FA per
gram sample was calculated using 19:0 methyl-ester as internal stan-
dard.
2.7. Plasma biochemistry
Blood samples were centrifuged at 3500 g for 10min to obtain the
plasma fraction. The plasma was separated into aliquots, snap-frozen in
liquid nitrogen and stored at −80 °C until further analysis. Plasma
concentrations of albumin and total protein, alanine aminotransferase
(ALAT), aspartate aminotransferase (ASAT), bile acids, bilirubin, crea-
tinine and lysozyme were measured on a PL multipurpose diagnostic
analyzer (Maxmat S.A., Montpellier, France) using DIALAB diagnostic
kits (Vienna, Austria). Osmolality was assessed by freezing point de-
termination, using a Fiske One-Ten osmometer (Fiske, VT, USA).
Sodium, potassium, chloride and free calcium in plasma were de-
termined using the Radiometer ABL-77 Blood gas and electrolyte ana-
lyzer (Radiometer, Copenhagen, Denmark).
2.8. Hematology
Hematocrit (Hct) was determined immediately from individual
sampled blood using Vitex Pari microhematocrit capillary tubes (Vitrex
Medical A/S, Denmark) and a microhematocrit centrifuge
(Haematofuge, Heraeus-Christ GmbH, Germany). The number of red
blood cells (RBC) and amount of hemoglobin (Hb) in full blood were
measured in a Cell Dyn 400 Hematological Analyzer (Sequoia- Turner)
according to the manufacturer's instructions, using Para 12 Extend
control blood (Streck, MedMark Ref:218777) for calibration. Mean
corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and
mean corpuscular hemoglobin concentration (MCHC) were calculated
from Hct, RBC and Hb as described in Sandnes et al. (1988).
2.9. Histology
Liver samples were fixated in 4% formaldehyde overnight, washed
in phosphate buffered saline (PBS) and then stored in 70% ethanol until
further processing. The fixed tissues were further dehydrated through
graded alcohols and xylene, and finally embedded in paraffin. Tissue
sections of 5 μm were then stained with haematoxylin and eosin (H&E)
and periodic acid-Schiff stain (PAS) for histopathological evaluation.
Sections were scanned with a ZEISS Axio Scan.Z1 (Carl Zeiss A/S,
Birkeroed, Denmark). After a first screening of the slides, the main
histopathological changes were considered for evaluation as these were
constantly present in most of the samples. These histopathological
changes were graded giving scores from 0 to 2 or 0 to 3 (see supple-
mentary data Table 1 for description of scoring). All analyses were
performed in a double-blinded format.
2.10. Statistics
In order to compare the results from this study with earlier pub-
lished studies on dietary Se toxicity in fish, the no observed adverse
effect levels (NOAEL) and lowest observed adverse effect levels
(LOAEL) were assessed by addressing significant differences among the
dietary treatments by one-way ANOVA. To account for the variance
among experimental tanks within a dietary treatment, as well as var-
iance among fish within an experimental tank, nested ANOVA, followed
by Tukey's HSD post-hoc test were used. All statistics were performed
using the program Statistica (Statsoft Inc., Tulsa,USA). In addition to
NOAEL and LOAEL assessment, a Benchmark dose (BMD) analysis was
conducted on the responses of the graded dietary exposures according
to the EFSA's benchmark dose technical guidance (EFSA 2017b). The
90% lower confidence interval of the BMD (BMDL) is used as alter-
native to NOAEL for assessing the feed concentration that is safe to use
with regards to animal health. For continuous data (whole body, organ
indices, plasma and blood parameters), two models (3 and 5) of ex-
ponential and Hill model families were fitted on individual data, using
the EFSA BMD platform (Proast, version 64.9 https://shiny-efsa.
openanalytics.eu/app/bmd). For quantal data (histology), seven
models (logistic, probit, log-logidtic, log probit, Weibull, gamma, and
LMS (two-stage)) were assessed on individual data in the EFSA BMD
platform. Selection of models (significantly better model fit) was based
on the Akaike information criterion (AIC). A default value of 2 units
difference between AICs is considered as the critical value by the EFSA
(EFSA 2017b). BMD models were accepted when the AIC of the model
was lower than the AIC of the null model (no dose response) -2
(AIC < AICnull-2), and the model with lowest AIC (AICmin) was lower
than the AIC of the full model +2 (AICmin<AICfull+2) (EFSA
2017b). Model averaging is recommended as the preferred method for
calculating the BMD confidence interval (EFSA 2017b), and model
averaging was performed for those data sets (quantal: histology para-
meters) where this option was available in the current version of Proast.
For data sets were no averaging option was available (continuous data:
whole body, organ indices, plasma and blood parameters) best model
based on AIC was used as described by the EFSA (EFSA 2017b). The
90% lower and upper confidence intervals for the BMD (BMDL and
BMDU, respectively) were estimated including bootstrap with standard
200 Bootstraps. The BMDL is defined as the dose not expected to give an
adverse effect. A default benchmark response (BMR) of 5% change was
used as starting point for model fitting of apparent adverse effects
(EFSA 2017b) such as reduced growth, altered organ indices or dis-
turbance in hematology (BMDL05). For markers of liver function and
osmoregulation (plasma enzymes and electrolytes) or markers of lipid
peroxidative stress (vitamin E, GSSSG and GSH), the BMR was ex-
panded as described in the EFSA technical guidance document (EFSA
2017b), and the BMDL for BMRs of 20% changes were considered
(BMDL20). For quantal and ordinal data (histology) the default BMR of
10% (extra risk; BMDL10) was used as described by the EFSA (EFSA
2017b).
Condition factor, specific growth rate, feed intake and feed con-
version rate were calculated with the following equations:
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⎝
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∗
−
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−Daily feed intake fish (FI)
Recorded feed intake tank day (g)
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1
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1
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⎝
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⎠
−
Feed conversion rate (FC) Total feed intake fish (g)
Body weight gain (g)
1
Organ somatic indices were calculated as the ratio of organ- to body
weight.
3. Results
3.1. Mortality and water quality
Fish fed dietary SeMet had no mortality in any of the dietary groups.
In contrast, fish fed selenite showed mortality when fed 29 and
60mg kg−1, these groups were therefore excluded from subsequent
analyses. Mortality in the highest selenite group started after
19–20 days of feeding while for the second highest exposure group
(29mg kg−1), mortality started after 29–31 days of exposure. The
dietary groups experiencing mortality were terminated when mor-
talities reached a pre-defined cut-off described in the animal research
approval, after 35 days of exposure. Model predicted mortality curves
gave best fitted (logistic) lethal time for 50% of the population (LT50)
of 34 (31–37.2, min-max.) days and 27 (27.2–29.6 min.-max.) days for
fish fed 29 and 60mg kg−1 selenite respectively. Apparent leaching of
Se from feces or pellets to the water seemed to be minimal (including
the two highest dietary selenite groups with mortality), as none of the
exposure groups had significantly higher (p < .05) waterborne Se le-
vels than the control group (ANOVA, tukey's t-test, n=3).The water-
borne Se levels (mean ± SD) in the experimental groups were
18.8 ± 11.7, 18.1 ± 8.1, 11.8 ± 2.3, 21.4 ± 1.0, 33.3 ± 6.2,
12.7 ± 2.7, 15.3 ± 2.4, 22.4 ± 11.3, 13.2 ± 2.2 (μg L−1), for the
control, 5, 11, 35, and 60mg kg−1 selenite groups and 6, 16, 21, and
39mg kg−1 SeMet groups, respectively.
3.2. Liver se levels
Fish from all exposure groups had significantly elevated liver Se
levels compared to the control group (Fig. 1). Besides fish fed 16 and
21mg kg−1 SeMet, fish fed graded levels of selenite or SeMet showed a
significant (p < .05) increase in liver Se levels with increased dietary
levels. Despite the higher dietary SeMet levels compared to dietary
selenite levels, fish fed selenite had significantly higher liver Se levels
than fish fed SeMet. Fish fed 5.4 and 11mg kg−1 selenite had sig-
nificantly (p < .05) higher liver Se levels compared to fish fed re-
spectively 6.2 and 16mg kg−1 SeMet. Even fish fed 11mg kg−1 selenite
had significantly higher liver Se levels compared to fish fed much
higher dietary SeMet levels of 39mg kg−1.
3.3. Weight, length, growth and organ index
Fish fed selenite levels of 11mg kg−1 had significantly reduced in-
dividual weights and lengths at the end of the 3month trial. Despite the
highest liver Se accumulation in this group, no significant differences
(p < .05) in liver somatic index (LSI, %) was seen compared to control
(Table 1). In contrast, the relative spleen somatic index (SSI, %) de-
creased with increased dietary selenite levels, with significantly re-
duced SSI in fish fed 11mg kg−1 selenite compared to the control fish.
No significant dietary differences were observed in specific growth rate
(SGR) or feed conversion (FCR) in fish fed any of the dietary selenite
groups (Table 1). Fish fed the highest dietary SeMet level (39mg kg−1)
had significantly reduced final individual weights and lengths, com-
pared to fish fed the second highest SeMet level (6.2 mg kg−1), but not
compared to the control fish. No significant differences were observed
in fish fed dietary 6.2 mg kg−1 SeMet compared to the control fish. No
significant differences were seen in any of the relative organ indexes
among the dietary SeMet groups. The SGR was significantly lower in
fish fed the highest SeMet group compared to all other SeMet groups,
including control. The FCR significantly increased with increasing
dietary SeMet levels, with significantly increased FCR in fish fed
39mg kg−1, compared to fish fed control, 6.2 and 16mg kg−1 SeMet,
respectively.
3.4. Blood and plasma parameters
A number of hematological indices were monitored at the end of the
exposure (Table 2). Significant differences were only observed for
MCHC and MCV for both selenite and SeMet exposed fish. Fish fed
11mg kg−1 selenite had significantly reduced MCHC compared to
control. For SeMet exposed fish fed 39mg kg−1, a significantly lower
MCHC and MCV was observed than the 16mg kg−1 SeMet exposed
group, however no significant differences were observed compared to
the control group. For plasma parameters as a marker for liver injury,
fish fed 11mg kg−1 selenite had only elevated alkaline phosphatase
(ALP), and fish fed 5.4mg kg−1 reduced alanine aminotransferase
(ALAT), compared to the control group. For fish exposed to SeMet,
plasma ALP and aspartate aminotransferase (ASAT) showed a sig-
nificant decrease in fish fed 39mg kg−1 SeMet, compared to control. Of
the plasma ions, only Ca was significantly reduced in fish fed
39mg kg−1 SeMet, while plasma osmolality, Na, Cl, and K were not
significantly affected by dietary SeMet exposures. Plasma markers of
kidney function and protein and energy metabolism, such as creatinine
and total protein, were also significantly reduced in fish fed the highest
SeMet level (39mg kg−1), compared to control fish. Selenite had no
significant effects on these parameters. Plasma ureic acid was reduced
in both SeMet and selenite fish, however, not significantly (p= .06, for
SeMet exposed fish) (Table 3).
Fig. 1. Selenium (Se) concentrations (mg kg−1 wet weight (ww)) in liver of
Atlantic salmon (Salmo salar) fed control, graded levels of selenite fortified diets
(5.4 and 11mg kg−1 ww, respectively), or graded levels of seleno-methionine
(SeMet) fortified diets (6.2, 16, 21, and 39mg kg−1 ww, respectively) for
3months (mean ± SD, n=15). Bars with the same letters are not significantly
different from each other (P < .05, one-way ANOVA, post hoc Tukey's t-test).
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3.5. Markers of lipid metabolism
As markers of altered lipid metabolism, sum total lipid was sig-
nificantly (p < .05) reduced compared to control group in fish fed
11mg kg−1 selenite and 39mg kg−1 SeMet (Fig. 2A). The relative (% of
sum lipid) distribution of lipid classes was significantly affected in the
11mg kg−1 selenite group with reduced TAG compared to control
groups (Fig. 2B). Although fish fed highest levels of SeMet also showed
decreased TAG, this difference were not significantly different com-
pared to control (p= .08, one-way ANOVA, Tukey's t-test).
3.6. Markers of oxidative stress
As markers of oxidative stress, reduced glutathione (GSH) was sig-
nificantly reduced compared to control group in fish fed 5.4 and
11mg kg−1 selenite and 16, 21, and 39mg kg−1 SeMet. The oxidized
glutathione (GSSG) was also significantly reduced in the same exposure
groups compared to the control fish, causing the ratio GSG: GSSG (data
not shown) not to be significantly altered among any of the exposure
groups compared to control fish. Fish fed the highest level of selenite
(11mg kg−1) and SeMet (39mg kg−1) had significantly reduced vi-
tamin E levels compared to control fish. No significant differences in
liver TBARS levels, an indicator for lipid peroxidative stress, were ob-
served in any of the exposure groups compared to control fish (Fig. 3).
3.7. Histopathology
Hepatocyte lipid intracytoplasmatic vacuolization, degeneration
and focal necrosis, and inflammation were the main histopathological
changes that were constantly present in most of the samples and these
histopathological changes were scored for semi-quantitative evaluation.
Significant differences among the dietary treatments were observed in
Table 1
Final individual length (cm), weight (gr), condition factor, relative liver somatic index (LSI, %), heart somatic index (HSI, %), spleen somatic index (SSI, %)
(mean ± SD, n=15), as well as tank specific growth rate (SGR), feed conversion ratio (FCR), and daily feed intake (FI) (mean ± SD, N=3), in Atlantic salmon
(Salmo salar) fed graded levels of selenite (5.4 and 11mg kg−1) and seleno-methionine (SeMet) (6.2, 16, 21, and 39mg kg−1) for 3months (triplicate tanks per diet).
Values with different superscripts are significantly different from each other (one-way ANOVA, Tukey's HSD test, p-values, p < .001, p < .01, p < .05).
Control Selenite 5.4 Selenite 11 p-Value
Final length 32.9 ± 1.8ab 33.7 ± 1.7a 31.8 ± 1.3b p < .001
Final weight 445 ± 102ab 469 ± 92a 411 ± 61b p < .05
Final CF 1.23 ± 0.10 1.21 ± 0.08 1.28 ± 0.09 0.33
Final LSI 1.01 ± 0.16 0.92 ± 0.12 0.99 ± 0.09 0.12
Final HSI 0.093 ± 0.013 0.11 ± 0.019 0.10 ± 0.012 0.19
Final SSI 0.099 ± 0.028a 0.077 ± 0.014ab 0.075 ± 0.018b p < .01
0–90 days
SGR 1.24 ± 0.10 1.26 ± 0.10 1.14 ± 0.03 0.21
FCR 0.80 ± 0.07 0.77 ± 0.07 0.89 ± 0.01 0.085
FI 0.99 ± 0.02 0.97 ± 0.02 1.01 ± 0.01 0.06
Control SeMet 6,2 SeMet 16 SeMet 21 SeMet 39 p-Value
Final length 32.9 ± 1.8ab 33.3 ± 2.0a 33.1 ± 1.8ab 32.2 ± 2.2ab 31.0 ± 1.6b p < .01
Final weight 445 ± 102a 467 ± 101a 458 ± 91a 405 ± 110a 352 ± 60b p < .05
Final CF 1.23 ± 0.10 1.25 ± 0.10 1.25 ± 0.09 1.18 ± 0.10 1.17 ± 0.08 0.06
Final LSI 1.01 ± 0.16 1.01 ± 0.08 0.94 ± 0.14 1.06 ± 0.12 1.01 ± 0.15 0.23
Final HSI 0.093 ± 0.013 0.096 ± 0.014 0.084 ± 0.019 0.098 ± 0.014 0.092 ± 0.019 0.41
Final SSI 0.099 ± 0.028 0.084 ± 0.019 0.090 ± 0.023 0.11 ± 0.034 0.12 ± 0.067 0.07
0–90 days
SGR 1.24 ± 0.10a 1.28 ± 0.09a 1.25 ± 0.03a 1.13 ± 0.08a 0.97 ± 0.07b p < .001
FCR 0.80 ± 0.07a 0.76 ± 0.08a 0.79 ± 0.01a 0.90 ± 0.06ab 1.13 ± 0.08b p < .001
FI 0.99 ± 0.02a 0.97 ± 0.03a 0.98 ± 0.02a 1.01 ± 0.02a 1.1 ± 0.02b p < .001
Table 2
Blood hematocrit (Hct, %), red blood cell count (RBC, number*10−12 L−1), hemoglobin (HGB, g 100mL−1), mean corpuscular volume (MCV, 10−5 L−1), Mean
corpuscular hemoglobin concentration (MCHC, g L−1), mean corpuscular hemoglobin (MCH μg) in Atlantic salmon (Salmo salar) fed graded levels of selenite (5.4 and
11mg kg−1) and seleno-methionine (SeMet) (6.2, 16, 21, and 39mg kg−1) for 3months (triplicate tanks per diet, mean ± SD, n= 15). Values with different
superscripts are significantly different from each other (one-way ANOVA, Tukey's HSD test, p < .001, p < .01, p < .05).
Control Selenite 5.4 Selenite 11 p-Values
Hct 43.5 ± 3.52 46.0 ± 2.55 46.9 ± 2.66 0.10
RBC 1.34 ± 0.129 1.42 ± 0.106 1.43 ± 0.087 0.29
HGB 9.88 ± 0.900 10.2 ± 0.61 10.3 ± 0.54 0.71
MCV 324 ± 9.3 324 ± 17.8 328 ± 13.9 0.87
MCHC 22.7 ± 0.85a 22.1 ± 0.62ab 21.9 ± 0.74b p < .05
MCH 73.7 ± 2.54 71.6 ± 3.39 72.1 ± 3.72 0.30
Control SeMet 6.2 SeMet 16 SeMet 21 SeMet 39 p-Values
Hct 43.5 ± 3.52 44.9 ± 2.21 45.0 ± 3.37 45.1 ± 3.50 43.6 ± 4.14 0.098
RBC 1.34 ± 0.129 1.39 ± 0.077 1.39 ± 0.092 1.42 ± 0.118 1.38 ± 0.11 0.55
HGB 9.88 ± 0.900 10.3 ± 0.52 10.2 ± 0.70 10.4 ± 0.80 10.1 ± 0.99 0.29
MCV 324 ± 9.3ab 323 ± 13.7ab 325 ± 15.7b 318 ± 13.4ab 315 ± 18.4a p < .01
MCHC 22.7 ± 0.85ab 22.8 ± 0.78ab 22.6 ± 0.81b 23.0 ± 0.48ab 23.1 ± 0.59a p < .05
MCH 73.7 ± 2.54 73.8 ± 3.06 73.5 ± 3.33 73.3 ± 2.21 72.8 ± 4.20 0.43
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two of the evaluated parameters, liver hepatocyte vacuolization
(p= .040) and degeneration and focal necrosis (p < .001). No sig-
nificant differences were observed in the parameter inflammation
among fish fed the different dietary treatment. Fish fed both 5.4 and
11mg kg−1 selenite had significantly higher hepatocyte degeneration
and focal necrosis compared to the control fish. Only fish fed the two
highest SeMet level (21 and 39mg kg−1) had significantly increased
focal necrosis compared to control fish. Fish fed the highest selenite
levels (11mg kg−1) had significantly reduced liver lipid intracytoplas-
matic vacuolization compared to control fish (Table 4).
For degeneration and focal necrosis, several patterns of lesions
could be observed. A common finding was the presence of basophilic
foci (Fig. 4a), which have been demonstrated to some degree to be
precursors of primary hepatocellular neoplasms. Diffuse presence of
hepatocyte hyalinization, characterized by enlarged hepatocytes that
contain discrete or pancytoplasmatic inclusions of refractile, eosino-
philic material was occasionally observed (Fig. 4b). Degenerated
hepatocytes presented a dark nucleus with condensed chromatin, pi-
knotic nuclei and were frequently surrounded by red blood cells and
oedematous areas (Fig. 4c). No inflammatory reaction was observed
surrounding the lesions. A mononuclear cell infiltrate was often ob-
served surrounding blood vessels (Figs. 5 A & B) and bile ducts (Figs. 5
C & D), although it could also be observed in the hepatic parenchyma.
3.8. Bench mark dose analyses
Parameter BMDL analyses as well as NOAEL and LOAEL assessments
are given in Table 5. For SeMet exposed fish, for whole body parameters
and organ indices, a BMDL could be assessed as the dose-response
model was significantly better than the response model that predicts no
dose response (null model) (AIC < AICnull-2), and the best fitted dose
response model (lowest AIC) was better than the full response model
(AICmin<AICfull+2) (Table 5). For hematology, blood plasma para-
meters, liver oxidative stress markers, and histopathology, no BMDL
Table 3
Plasma biochemistry alkaline phosphate (ALP, Units L−1), Alanine aminotransferase (ALAT, U L−1), aspartate aminotransferase (ASAT, U L−1), glucose (mmol),
albumin (μmol), creatinine (μmol), total protein (g L−1), ureic acid (μmol), and ions Na, K, Cl (mmmol) and osmolality (Osm, mOsm) in Atlantic salmon (Salmo salar)
fed graded levels of selenite (5.4 and 11mg kg−1) and seleno-methionine (SeMet) (6.2, 16, 21, and 39mg kg−1) for 3months (triplicate tanks per diet, mean ± SD,
n= 15). Values with different superscripts are significantly different from each other (one-way ANOVA, Tukey's HSD test, p < .001, p < .01, p < .05).
Control Selenite 5.4 Selenite 11 p-Values
ALP 448 ± 168a 624 ± 143ab 720 ± 204b p < .01
ALAT 13.5 ± 3.14a 21.2 ± 5.6b 19.4 ± 1.42b P < .05
ASAT 339 ± 104 332 ± 52 320 ± 84 0.13
glucose 5.19 ± 0.79 5.77 ± 1.05 4.79 ± 0.56 0.36
albumine 301 ± 43 315 ± 24 321 ± 29 0.26
creatinine 17.7 ± 6.47 15.7 ± 5.26 14.8 ± 4.99 0.37
tot prot 41.4 ± 7.31 42.5 ± 5.12 42.6 ± 3.72 0.83
Ureic acid 45.1 ± 12.1 30.6 ± 11.9 28.6 ± 15.2 0.51
Osm 322 ± 4.64 322 ± 5.17 322 ± 4.04 0.89
Ca 2.67 ± 0.18 2.77 ± 0.13 2.72 ± 0.92 0.12
Cl 139 ± 8.78 134 ± 10.6 137 ± 10.0 0.94
Na 169 ± 2.55 169 ± 2.41 169 ± 2.89 0.61
K 1.53 ± 0.45 1.10 ± 0.37 0.86 ± 0.28 0.43
Control SeMet 6,2 SeMet 16 SeMet 21 SeMet 39 p-Values
ALP 448 ± 168a 601 ± 155a 566 ± 153ab 512 ± 196ab 422 ± 17b p < .01
ALAT 19.5 ± 7.14 18.3 ± 10.9 15.1 ± 9.86 12.3 ± 7.66 15.5 ± 10.0 0.12
ASAT 339 ± 104a 384 ± 105a 330 ± 81a 333 ± 110a 253 ± 91b p < .05
Glucose 5.19 ± 0.79 5.17 ± 0.53 5.33 ± 0.85 5.72 ± 1.39 5.63 ± 1.33 0.31
Albumine 301 ± 43 325 ± 30 309 ± 36 287 ± 35 284 ± 39 0.085
Creatininee 17.7 ± 6.47a 20.2 ± 7.17a 15.3 ± 6.33a 13.4 ± 6.78a 10.8 ± 4.61b p < .01
Tot prot 41.4 ± 7.31a 44.9 ± 5.40a 42.59 ± 5.56a 40.18 ± 7.58a 37.3 ± 6.05b p < .01
Ureic acid 45.1 ± 12.1 51.1 ± 15.4 43.3 ± 18.1 52.7 ± 21.9 35.4 ± 19.1 0.06
Osm 322 ± 4.64 322 ± 3.64 322 ± 4.78 323 ± 4.17 321 ± 5.92 0.86
Ca 2.67 ± 0.18a 2.74 ± 0.14a 2.68 ± 0.19a 2.68 ± 0.18a 2.53 ± 0.12b p < .01
Cl 139 ± 8.78 139 ± 10.6 140 ± 8.28 136 ± 13.5 140 ± 10.1 0.94
Na 169 ± 2.55 170 ± 3.09 169 ± 3.03 168 ± 2.24 169 ± 2.37 0.43
K 1.53 ± 0.45 1.26 ± 0.45 1.06 ± 0.50 1.24 ± 0.73 1.52 ± 0.46 0.46
Fig. 2. Liver sum lipid (mg kg−1 ww)(A), relative
triacylglycerol (TAG, % sum lipid) (B), in Atlantic
salmon (Salmo salar) fed control, graded levels of
selenite fortified diets (5.4 and 11mg kg−1 WW, re-
spectively), or graded levels of seleno-methionine
(SeMet) fortified diets (6.2, 16, 21, and 39mg kg−1
WW, respectively) for 3 months (mean ± SD,
n=3). Bars with * are significantly different from
control (P < .05, one-way ANOVA, post hoc Tukey's
t-test).
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could be established for all parameters because none of the fitted dose-
response models were significantly better than the null model (AIC >
AICnull-2, indicated with “none” in Table 5). For selenite exposed fish,
for fewer parameters than for SeMet exposed fish, a BMDL could be
established. This is due to the use of only three experimental groups in
the selenite dose-response assessment compared to five in the SeMet
exposed fish (see mortality above). As for SeMet, a lack of BMDL was
due to no significant difference of the dose-response models compared
to the “null” model (AIC < AICnull-2, indicated as “none” in Table 5).
In addition, for several parameters (Hct, RBC, plasma glucose and
creatinine, GSH, GSSG, and hepatocyte lipid intracytoplasmatic va-
cuolization), the best fitted dose response model was not significantly
different from the full model (AICmin<AICfull+2, indicated with “*”
in Table 5). This was not attributed to non-random errors (e.g. data
error), but rather that none of the models were appropriate for the
selenite data set (EFSA 2017b), which can be attributed to the use of
only 3 selenite dietary exposure groups.
For the SeMet exposed fish, the parameter|rs with the lowest BMDL
Fig. 3. Liver reduced glutathione (GSH) (A), oxi-
dized glutathione (GSSG (B), vitamin E (as alpha-
tocopherol) (C) and thiobarbituric acid reactive
substances (TBARS) (D) in Atlantic salmon (Salmo
salar) fed control, graded levels of selenite fortified
diets (5.4 and 11mg kg−1 ww, respectively), or
graded levels of seleno-methionine (SeMet) fortified
diets (6.2, 16, 21, and 39mg kg−1 ww, respectively)
for 3 months (mean ± SD, n= 15). Bars with * are
significantly different from control (P < .05, one-
way ANOVA, post hoc Tukey's t-test).
Table 4
Score for the main histopathological changes (hepatocyte intracytoplasmatic
vacuolization, degeneration and focal necrosis and inflammation) in liver of
Atlantic salmon (Salmo salar) fed control, graded levels of selenite fortified diets
(5.4 and 11mg kg−1 WW, respectively), or graded levels of seleno-methionine
(SeMet) fortified diets (6.2, 16, 21, and 39mg kg−1 WW, respectively) for
3 months (mean ± SD, n=9). Different superscript letters denote significant
differences among the dietary treatments (p < .05). Group mean scores were
compared using Pearson's X2 (level of confidence 95%).
Vacuolization Degeneration and focal necrosis Inflammation
Control 1.4 ± 0.9a 0.3 ± 0.2c 0.2 ± 0.4
SeMet 6.2 0.9 ± 0.9ab 0.5 ± 0.2bc 0.6 ± 0.5
SeMet 16 0.8 ± 0.4ab 0.7 ± 0.4abc 0.6 ± 0.5
SeMet 21 0.8 ± 0.7ab 0.8 ± 0.5ab 0.2 ± 0.3
SeMet 39 0.9 ± 0.6ab 1.1 ± 0.2a 0.4 ± 0.3
Selenite 5.4 0.7 ± 0.8ab 1.0 ± 0.5ab 0.5 ± 0.4
Selenite 11 0.3 ± 0.5b 1.0 ± 0.4a 0.6 ± 0.8
Fig. 4. (A–C) - Several degenerative and necrosis
associated lesions observed in sections (5 μm) from
the liver of Atlantic salmon fed selenite 11mg kg−1
(a), seleno-methionine (SeMet) 21mg kg−1(b) and
selenite 5.4 mg kg−1 (c) for 3months. (a) Basophilic
focus (asterisk) of degeneration showing smaller
cells than normal hepatocytes arranged in cords. (b)
Focal degeneration and necrosis clearly differ-
entiated from a healthy area (dark asterisk). In the
degenerated area the presence of hyaline substance
can be clearly observed (white asterisk) and oedema
(arrow) together with fat vacuoles (arrowhead) re-
sulting from the rupture of hepatocytes and not di-
rectly due to vacuolization of the cells. (c) Higher
magnification of degenerated area where a normal
hepatocyte (arrowhead) with vacuolated cytoplasm
and characteristic nucleus can be observed next to
degenerated hepatocytes with contracted cytoplasm
and basophilic nucleus. Fat vacuoles resulting from
the rupture of degenerated cells can also be observed
(asterisks). Haematoxylin and Eosin staining.
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were spleen somatic index, plasma creatinine, and histopathological
degeneration and focal necrosis, with a BMDL05, BMDL20 and BMDL10
of 3.05, 2.29, and 2.8 mg SeMet kg−1 feed, respectively. However, for
spleen somatic index and plasma creatinine, a large variation in the
90% lower and upper 90% confidence interval (BMDL and BMDU, re-
spectively) was seen as a BMDL:BMDU ratio exceeding 10 (Table 5).
This indicates a large variation and uncertainty BMD model assessment.
For the histopathological parameter degeneration and focal necrosis,
the BMDL:BMDU ratio was far less (0.4), with a more certain BMD
assessment. For histological quantal data, a standard BMDL10 with extra
risk factor is included in EFSA's BMD model, which is specific for ad-
verse histological effect. For the SeMet exposed fish, the lowest BMDL
with a high certainty (low variation BMDL and BMDU) and use of extra
risk factor (EFSA 2017b) was the histological focal necrosis observation
at 2.1mg SeMet kg−1.
For selenite exposed fish, lowest BMDLs were for spleen somatic
index and plasma ALP, K, creatinine, and ureic acid, with a BMDL05 of
0.002, and a BMDL20 of 0.059, 0.066, 0.026 and 0.017mg selenite mg
kg−1, respectively (Table 5). However, for all these parameters, a large
variation in BMDL and BMDU was observed (BMDL:BMDU ratio of
2239, 90, 127, 595 and 189 respectively), indicating an uncertain BMD
assessment. Similarly for Hct and RBC, a BMDL05 of 0.43 and 0.41mg
selenite mg kg−1 was assessed, but both parameters had a high
BMDL:BMDU ratio (64 and 467, respectively). In addition, the best
fitted dose response model for Hct and RBC, was not significantly dif-
ferent from the full model (AICmin<AICfull+2, indicated with “*” in
Table 5). For the liver oxidative stress and histology parameters, GSSG
and intracytoplasmatic vacuolization had the lowest BMDL20 of 0.23
and BMDL10 of 0.06mg selenite kg−1, respectively. However, also for
these parameters a high BMDL:BMDU and/or a best fit model that was
not significantly different from the full model, indicated an uncertain
BMDL assessment for these parameters. Other parameters in plasma
liver parameters, oxidative stress, and histopathology (plasma ALAT,
liver vitamin E, and histological focal necrosis, respectively) had a low
BMDL:BMDU (ratio < 10) variation and a best fit dose-response that
was significantly better than the null and full fit, with lowest BMDL20
and BMDL10 of 1.4, 1.6, and 1.9mg selenite kg−1, respectively. Besides
for total protein plasma content, for all parameters the BMDL was lower
than the ANOVA established NOAEL (Table 5).
4. Discussion
4.1. Mortality, growth, and hematology
In general, inorganic Se is considered more toxic than organic Se
forms (Thiry et al., 2012). However, also for the organic SeMet a
narrow window of requirement and toxicity has been observed for Nile
tilapia (Oreochromis niloticus) (Lee et al. 2016), and juvenile rainbow
trout appears to have threshold levels for chronic dietary SeMet toxicity
that is in the same range as for dietary selenite (Hamilton 2004; Vidal
et al. 2005).
In the present study, selenite was more acute toxic than SeMet, as
exposure to 29mg kg−1 selenite (0.29mg kg−1 body weight (bw)
day−1) caused acute toxicity while fish fed up to 39mg kg−1 ww SeMet
(0.39 mg kg−1 bw day−1) showed no mortality. In the present trial, a
feed level of 11mg k−1 selenite kg ww (0.11mg kg−1 bw day−1) was
not acute toxic to the fish, as was also observed in earlier trails with
larger Atlantic salmon (572 g) fed 15mg kg−1 (0.14mg kg−1 bw
day−1) (Berntssen et al. 2017). A narrow range seems to exist between
sublethal chronic toxicity and acute toxicity (mortality), as a 2.6 fold
increase from none acute toxic dietary selenite levels gave mortality in
the present study (0.11 versus 0.29mg kg−1 bw day−1, respectively).
Atlantic salmon and rainbow trout seem to have the same sensitivity to
excess dietary selenite exposure, as rainbow trout fry (1.3 g) fed with a
daily dose in the same range as the present study (0.38 versus
0.29mg kg−1 bw day−1, present study) showed mortality (Hilton et al.
1980). In contrast, rainbow trout start-feeders (0.6 g) fed up to
11.4 mg kg−1 selenite (estimated 0.52mg kg−1 bw day−1) showed a
marginal, but none significantly, mortality (Hilton and Hodson 1983).
Similar as for Atlantic salmon in the present study, SeMet fed rainbow
trout (0.28–26 g) or cutthroat trout (9.7 g) did not show mortality at
any of the dietary exposure studies with feed levels ranging from>7.4
to 18mg SeMet kg−1 dw (0.14–0.31mg kg−1 bw day−1) (Vidal et al.
2005; Rider et al. 2009; Hardy et al. 2010; Knight et al. 2016). In
contrast, for chinook salmon (~ 1 g) fed 9.6 mg kg−1 SeMet, survival
was reduced (Hamilton et al. 1990) (Table 6), thus emphasizing the
salmonid species difference in sensitivity towards dietary Se toxicity.
For overall none-lethal adverse effects that are not specifically re-
lated to Se toxic pathways, growth was significantly reduced at 11mg
selenite kg−1 ww (0.11mg kg−1 bw day−1). Similarly, earlier Atlantic
salmon fed 15mg selenite kg−1 ww with a slightly higher daily dose
exposure (0.14mg kg−1 bw day−1) showed reduced growth (Berntssen
et al. 2017). In contrast, rainbow trout (26 g) fed a similar daily selenite
Fig. 5. (A–D)- Sections (5 μm) from Atlantic salmon
liver fed the diets selenite 5.4 mg kg−1 (a), selenite
11mg kg−1 (b & d) and seleno-methionine (SeMet)
16mg kg−1(c) for 3 months. A mononuclear (mainly
lymphocytes) inflammatory reaction could be ob-
served (asterisk) surrounding the blood vessels (a &
b) and the bile ducts (c & d). Moderate periductular
fibrosis can be observed in (d) (arrow).
Haematoxylin and Eosin staining.
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dose (0.14 mg kg−1 bw day−1) showed no reduced growth (Rider et al.
2009), and only daily selenite dose as high as 0.38–0.52mg kg−1 bw
day−1 caused growth impairment in juvenile (0.6–1.3 g) rainbow trout
(Hilton et al. 1980; Hilton and Hodson 1983). Atlantic salmon fed
21mg kg−1 (0.21 mg kg−1 bw day−1) SeMet, had no significantly re-
duced growth in the present trial. For other SeMet exposed salmonids,
however, initial-feeding (0.3–0.4 g) rainbow trout had reduced growth
at lower estimated SeMet daily doses (estimated 0.04mg kg−1 bw
day−1 or 0.12mg kg−1 bw day−1, respectively)(Vidal et al. 2005;
Knight et al. 2016). In contrast, adult rainbow trout (26–100 g) fed
7.4–8.9mg SeMet kg−1 (0.15–0.18mg kg−1 bw day−1) had no reduced
growth (Rider et al. 2009; Pacitti et al. 2016a) (Table 6).
In the present study, no significant differences were observed in
hematocrit, hemoglobin, or red blood cells counts, despite apparent
adverse effects such as liver histopathology (see below) and mortality
(above) in selenite fed fish. Thus indicating that hematology, as a
general adverse effect parameter, is not applicable for dietary Se toxi-
city assessment. Similarly in other studies on rainbow trout, the
Table 5
Benchmark doses (BMD), lower and upper 90% confidence interval (BMDL and
BMDU, respectively), ration BMDL to BMDU (BMDL/BMDU), No Observed
(Adverse) Effect Level (NOAEL/NOEL), and lowest observed (adverse) effect
level (LOAEL/LOEL) for relevant responses in Atlantic salmon (Salmo salar L.)
fed to graded levels of selenite and seleno-mentionine (SeMet) for 90 days. For
parameter abbreviations see main text.
Selenomethionine
Whole body parameters BMDL05 BMUL05 BMDU/
BMDU
NOAEL LOAEL
SGR 8.48 26.8 21 39
FCR 7.78 22.9 2.95 21 39
FI 20.4 33.5 21 39
Weight 7.98 27.1 3.41 21 39
Length 26.9 42.0 1.56 21 39
CF 23.7 53.2 2.24 39
Organ indices
HSI None None 39
LSI None None 39
SSI 3.05 31.7 10.39 39
Heamatology
HCT None None 39
RBC None None 39
HGB None None 39
MCV None None 21 39
MCHC None None 21 39
MCHC None None 39
Plasma parameters BMDL20 BMDU20 BMDU/
BMDU
NOAEL LOAEL
ALP None None 21 39
ALAT None None 39
ASAT 19.7 40 2.03 21 39
Glucose None None 39
Albumine None None 39
Creatinine 2.29 31.3 13.7 21 39
Tot prot 37.6 120 3.19 21 39
Ureic acid None None 39
Osm None None 39
Ca None None 21 39
Cl None None 39
Na None None 39
K None None 39
Liver oxidative stress markers
TBARS None None 39
Vitamin E 10.8 22.1 2.00 21 39
GSH 4.71 26.9 5.80 6.2 16
GSSG 6.91 15.5 2.20 6.2 16
GSH/GSSG ratio None None 39
Lipid BMDL20 BMDU20 BMDU/
BMDU
NOAEL LOAEL
Sum lipid 31 358 11 21 39
% FFA None None 11
% TAG None None 5.4 11
%DAG None None 11
Histology BMDL10 BMDU10 BMDU/
BMDU
NOAEL LOEAL
Degeneration and focal
necrosis
2.8 4.51 1.6 21 39
Inflammation None None 39
Intracytoplasmatic
vacuolization
None None 39
Selenite
Whole body parameters BMDL05 BMUL05 BMDU/
BMDU
NOAEL LOAEL
SGR None None 11
FCR 4 10.8 2.7 11
FI 10.5 15.9 1.51 11
Weight None None 5.4 11
Lenght None None 5.4 11
CF 7.53 25.6 3.4 11
Table 5 (continued)
Selenite
Organ indices BMDL05 BMUL05 BMDU/
BMDU
NOAEL LOAEL
HSI None None 11
LSI None None 11
SSI 0.002 4.12 2060 5.4 11
Blood parameters BMDL05 BMUL05 BMDU/
BMDU
NOAEL LOAEL
HCT 0.428* 27.2* 63.55 11 –
RBC 0.407* 190* 466.83 11 –
HGB None None 11 –
MCV None None 11 –
MCHC None None 5.4 11
MCHC None None 11 –
Plasma parameters BMDL20 BMDU20 BMDU/
BMDU
NOEL LOEL
AP 0.059 5.32 90.17 5.4 11
ALAT 1.36 10.8 7.94 11 –
ASAT None None 11 –
Glucose 10.8* 62.4* 5.77 11 –
Albumine None None 11 –
Creatinine 0.0262* 15.6* 595 11 –
Tot prot None None 11 –
Ureic acid 0.0168 3.17 189 11 –
Osm None None 11 –
Ca None None 11 –
Cl None None 11 –
Na None None 11 –
K 0.066 8.4 127.3 11 –
Liver oxidative stress BMDL20 BMDU20 BMDU/
BMDU
NOEL LOEL
Liver TBARS none none 11 –
Liver vit E 1.62 9.02 5.57 5.4 11
GSH 3.67* 136* 37.06 0.45 5.4
GSSG 0.203* 7.28* 35.86 0.45 5.4
Lipid BMDL20 BMDU20 BMDU/
BMDU
NOAEL LOAEL
Sum lipid 3.97 200 50 5.4 11
% FFA None None 11
% TAG 0.36 125 347 5.4 11
%DAG None None 11
Histopathology BMDL10 BMDL10 BMDU/
BMDU
NOAEL LOAEL
Degeneration and focal
necrosis
1.89 7.21 3.81 0.45 5.4
Inflammation None None 11 –
Hepatocyte
intracytoplasmatic
vacuolization
0.06* 0.19* 2.86 5.4 11
AICmin<AICfull+2. indicated with “*”.
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apparent dietary selenite induced toxicity was not expressed as altera-
tions in hematology (Hilton et al. 1980; Hilton and Hodson 1983).
However, organic selenium fed bluegill (Lepomis macrochirus) showed
abnormally shaped erythrocytes (Finley 1985), and combined water-
borne and dietary selenium exposed green bluegill showed significant
reduced hematocrit, causing a lowered mean corpuscular hemoglobin
concentration (MCHC), which is a measure of the concentration of
hemoglobin in a given volume of packed red blood cells, and reduced
MCHC causes impaired respiratory capacity (Lemly 1993b). In the
present study, fish fed 11mg kg−1 selenite or 16mg kg−1 SeMet had
reduced MCHC, although the individual concentration of hemoglobin
and red blood cells did not alter significantly, which reflects a reduced
hemoglobin per red blood cell, possibly affecting the oxygen carrying
capacity in dietary Se exposed Atlantic salmon.
4.2. Organ toxicity
In the present study, liver Se levels were higher in fish fed dietary
selenite compared to fish fed SeMet, as was observed in earlier trials
(Berntssen et al. 2017). Dietary selenite and SeMet seem to distribute
differently, whereas selenite accumulated relatively more in liver,
SeMet accumulated relatively more in whole fish and muscle (Berntssen
et al. 2017). This preferential accumulation of SeMet in muscle and
whole body compared to selenite, is attributed to the difference in
metabolism of SeMet compared to selenite (Rider et al. 2009; Fontagne-
Dicharry et al. 2015; Godin et al. 2015). Selenomethionine can be di-
rectly and nonspecifically incorporated in any protein containing me-
thionine, while selenite needs to form hydrogen selenide (H2Se) before
being incorporated in specific selenoproteins (Suzuki 2005; Godin et al.
2015). In the present study, the higher liver loads were associated with
more prevailed liver toxicity for selenite fed Atlantic salmon compared
to SeMet fed Atlantic salmon. The most clear liver histopathological
finding was hepatocyte degeneration and focal necrosis, which oc-
curred significantly in fish fed 5.4mg selenite kg−1 or fish fed 21mg
SeMet kg−1 ww. The hepatic somatic index, however, was not sig-
nificantly altered in any of the selenite and SeMet fed fish. In addition,
increased inflammation was observed in both selenite and SeMet fed
fish, however, none of these changes were significant. Earlier studies
Table 6
Literature overview of none observed adverse effect level (NOAEL) and lowest observed adverse effect levels (LOAEL) in rainbow trout (Oncorhynchus mykiss) and
Atlantic salmon (Salmon salar) fed graded levels of inorganic or organic selenium.
NOAEL LOAEL Feed
intake
Se form Length Endpoint Reference
mg kg−1 mg kg−1 % BW/
Day
Days Exposure range
Rainbow trout
79 g ? 9mg kg−1 ? Selenite 294 days Mortality Hamilton, 2004
From Hamilton, 2004
1.3 g 3.67mg kg−1 DW 13mg kg−1 DW 2.9* Selenite 140 days Mortality/growth/FCR Hilton et al. 1980
13.06mg kg−1 DW * No hematology, no
histopathology
0.07, 0.15, 0.28, 25, 3.67,
13.06mg kg−1
0.6 g 11.4mg kg−1 DW * 112 days No significant mortality Hilton and Hodson 1983
6.6mg kg−1 DW 11.4 mg kg−1 DW 4.6* Reduced growth 0.6, 6.6, 11.4mg kg−1 DW
11.4mg kg−1 DW * No hematology or blood plasma parameters
26 g 7.1mg /kg ww * 2 Selenite 70 days no reduced growth FCR/no
oxidative stress/Hct
Rider et al. 2009
3.9mg kg−1 ww 7.1 mg kg−1 ww Increased oxidative stress after
physical stress
0.73, 2.3, 3.9, 7.1mg kg−1 ww
26 g 7.4mg kg−1 ww 2 Se-yeast 70 days No mortaility no redued growth Rider et al. 2009
0.73, 2.4, 4.1, 8 mg kg−1 ww
0.37 g 2.4mg kg−1 DW 4.6 mg kg−1 DW 0.8 * Selenomethionine 90 days Reduced growth, Vidal et al. 2005
18mg kg−1 DW No mortaolity or oxidative stress 0.23, 4.6, 12, 18mg kg DW
33.47 g 3mg kg−1 WW * ? Se yeast Sel-Pex No growth reduction or oxidative
stress
Hunt et al. 2011
Control, 2, 3, 4 mg kg−1
0.28 g 1.3mg kg−1 DW 7.1–19.5mg kg−1 DW 1.6** Semet worm 60 days Reduced final weight Knight et al. 2016
7.1mg kg−1 DW 19.5 mg kg−1 DW Reduced liver
TAG
1.3, 7.1, 10.7, 19.5, 31.8mg kg−1
DW
1.3mg kg−1 DW 7.1 mg kg−1 DW Microarray lipid metabolism
100 g 8.94mg kg−1 ww * 2 Se-Plex 70 days No reduced growth Pacitti et al. 2015
0.87, 1.46, 4.81, 8.94mg kg−1
ww
Atlantic salmon
147 g 5.4 mg kg−1 11mg kg−1 Selenite 90 days Mortality This study
0.45mg kg−1 5.4 mg kg−1 1.1 Histopathology plasa enzymnes 0.45, 5.,4, 11, 29, 60mg kg−1 WW
0.45–5.4mg kg−1 5.4–11mg kg−1 Oxidatve stress (GSSG and vit E,)
572 g 15mg kg−1 ww * Selenite 90 days No mortality Berntssen et al. 2017
1mg kg−1 ww 15mg kg−1 ww Reduced growth 0.35, 1, 15mg kg−1 WW
1mg kg−1 ww 15mg kg−1 ww 0.9 Oxidatev stress (GSSG and vit E)
1mg kg−1 ww 15mg kg−1 ww Metablomics lipid pathway distrubance
147 g 39mg kg−1 ww * Selenomentionine 90 days No mortality This study
21mg kg−1 ww 39mg kg−1 ww 1.1 Histopathology plasma enzymens 0.45, 6.2, 16, 21, 39mg kg−1 ww
6.2–21mg kg−1 ww 16–39mg kg−1 ww oxidatives tress (GSH+GSSG and Vit E)
572 g 15mg kg−1 WW * 0.9 selenomentionine 90 days No mortality, reduced growth, oxidative stress Berntssen et al. 2017
1mg kg−1 ww 15mg kg−1 ww Metablomics lipid pathway distrubance 0.35, 2, 15mg kg−1 WW
*Estimated daily feed intake based on given specific growth rate (SGR) and feed conversion factor (FCR).
**Estimated feed intake based on conversion of wet weight daily feed intake of worms to feed concentration expressed as dry weight on the assumption of 30% dry
material.
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with other fish species also showed liver histopathological changes in
liver such as hepatocellular vacuolar degeneration and necrosis in ex-
cess dietary organic Se exposed white sturgeon (Acipenser transmon-
tanus) (Tashjian et al. 2006) or bluegill (Finley 1985). In contrast, other
studies with white sturgeon fed graded levels of SeMet showed a dose-
dependent (1.4–104mg kg−1 dw) increase in frequency and size of
melanomacrophage aggregates, but had no liver necrosis or general cell
damage (De Riu et al. 2014; Zee et al. 2016a). Furthermore, in contrast
to the present study, rainbow trout fed 13mg kg−1 selenite had no
histopathological lesions (Hilton et al. 1980). In the present study, the
observed histopathological findings in liver were associated with ele-
vated plasma ALP and ALAT (fish fed 5.4 and 11mg kg−1 selenite,
respectively), which are markers of liver toxicity due to loss of liver
specific enzymes to the blood stream. Only fish fed 39mg SeMet kg−1
showed altered AP and ASAT levels, attributable to the lower potential
of dietary SeMet to cause liver pathology/toxicity compared to dietary
selenite. In addition to liver toxicity, both dietary selenite and SeMet
are also known to induce renal toxicity observed as morphological al-
terations (Hilton et al. 1982; Finley 1985; Tashjian et al. 2006; De Riu
et al. 2014; Zee et al. 2016a). The present study did not include his-
topathology evaluation of kidney, however, plasma markers of renal
function such as plasma creatinine and total protein were significantly
altered in Atlantic salmon fed 39mg kg−1 SeMet, while fish fed selenite
displayed normal values. In addition, plasma ureic acid decreased in
both SeMet and selenite exposed Atlantic salmon (see benchmark dose
assessment under), however, with no significant ANOVA difference
among the exposure groups. Interestingly, SeMet and selenite had no
significant effect on osmoregulation as seen from unaltered plasma
osmolality, K, Na, and Cl, although plasma Ca was significantly reduced
in SeMet fed Atlantic salmon. Fish exposed to dietary or waterborne
selenium showed renal calcinosis and deposits in earlier rainbow trout
studies (Hilton and Hodson 1983).
4.3. Markers of lipid and oxidative stress
In the present study, for Atlantic salmon fed 11mg kg−1 selenite a
significant reduction in lipid intracytoplasmatic vacuolization was ob-
served. Concurrently, total liver lipid was reduced in fish fed
11mg kg−1 selenite or 39mg kg−1 SeMet exposed fish, with sig-
nificantly reduced liver TAG in 11mg kg−1 selenite fed fish. Earlier
dietary SeMet fish studies showed an altered energy storage (De Riu
et al. 2014) as seen from liver histological changes such as cytoplasmic
glycogen depletion (Teh et al. 2004; De Riu et al. 2014) and fatty va-
cuolar degeneration (Teh et al. 2004; Zee et al. 2016a). Furthermore, as
in the present study, juvenile rainbow trout exposed to selenized-yeast
worms had reduced liver TAG content and disturbed lipid synthesis and
metabolism (Knight et al. 2016; Pacitti et al. 2016b; Berntssen et al.
2017). Wide-scope transcriptomic assessment showed that organic Se
increased the expression of networks for growth related signaling cas-
cades in addition to those related to fatty acid synthesis and metabolism
(Knight et al. 2016). The disruption of metabolites related to TAG
processing and storage, as well as liver gene networks for epidermal
growth factor and Notch signaling, were suggested to represent key
molecular initiating events for adverse outcomes related to growth and
Se toxicity in fish (Knight et al. 2016). As reported in earlier Atlantic
salmon trials (Berntssen et al. 2017), markers of oxidative stress such as
GSH and vitamin E, were some of the most sensitive responses to both
selenite and SeMet exposures. Oxidative stress has been suggested as a
main mode of action (MOA) in selenite and SeMet induced toxicity in
fish (Miller et al. 2007; Misra and Niyogi 2009; Misra et al. 2012;
Hursky and Pietrock 2015; Lee et al. 2015). It has to be noted that more
recent studies reported dietary SeMet induced toxicity without clear
oxidative stress in rainbow trout and white sturgeon (Knight et al.
2016; Zee et al. 2016b). In vitro trails on rainbow trout hepatocytes,
showed an increase in antioxidant enzymes together with reduced le-
vels of GSH and GSH:GSSG ratio (Misra and Niyogi 2009). The
reduction of GSH at high dietary Se exposures can be due to the role of
GSH in the anti-oxidant defense as substrate to anti-oxidant enzymes
(e.g. glutathione peroxidase) or as direct antioxidant. In addition, GSH
is consumed in the metabolism of selenite in the formation of hydrogen
selenide on its way in being incorporated in selenoproteins (Suzuki
2005; Godin et al. 2015). The metabolisation of both selenite itself can
cause oxidative stress in the form of formation of reactive oxidative
substances in formation of hydrogen selenide (Lin and Spallholz 1993).
Excess SeMet is methylated to methylselenol for further excretion
(Suzuki 2005). The redox cycling of these methylselenols in the pre-
sence of GSH has been suggested to produce oxidative stress (Palace
et al. 2004). In the present trial, both GSH and GSSG were lowered and
the ratio GSH:GSSG was not altered indicating that total GSH was used
as part of Se and SeMet cellular metabolism rather than anti-oxidant
role. The latter could also explain the sensitive (at lowest dose) GSG/
GSSG response. The depletion of vitamin E indicates oxidative stress,
which was more pronounced in selenite exposed fish compared to
SeMet exposed fish (significant decrease at 11mg kg−1 selenite versus
39mg kg−1 SeMet). The oxidative stress did not lead to a significant
formation of lipid peroxidation, as seen from increased TBARS, as was
reported in an earlier trial (Berntssen et al. 2017)
4.4. Comparison literature NOAEL and LOEAL and bench mark dose
Table 2 in the supplementary material gives an overview of the
reported NOAEL and LOAEL in previous studies on graded (more than
two exposure groups) levels of organic and inorganic selenium in sev-
eral fish species. The present paper will focus on comparing the studies
on rainbow trout and Atlantic salmon (summarized in Table 6). As none
of the previous studies have used bench mark dosing to assess safe le-
vels of dietary exposure, the NOAEL and LOAEL of this study are given
as well. The earlier established NOAEL will be compared with the newly
assessed BMDL from this study as a safe limit for Se supplementation
with regards to feed safety.
The lowest LOAEL for SeMet in rainbow trout variated from
0.071–0.12mg kg−1 bw day−1 (Vidal et al. 2005; Knight et al. 2016)
and for selenite from 0.14–0.45mg kg BW−1 day−1 (Hilton et al. 1980;
Rider et al. 2009). This variation depends on life stage, relative feed
intake, form of Se inclusion (as Se-yeast, L-SeMet, or part of natural
feed), duration of exposure, and selected end-points of toxicity. Espe-
cially converting feed concentrations to daily dose per kg body weight
is of importance for comparison of studies using different life stages, as
relative daily feed intake (and hence daily Se dose) decreases with in-
creased fish size (Austreng et al. 1987). The wide range of LOAEL and
higher LOAEL for selenite than SeMet, indicates the difficulty estab-
lishing threshold levels of toxicity when comparing literature, even
from one species and with correction for assumed feed intake.
The assessment of safe limits is even more variable as the lowest
NOAEL is often expressed as the control group, with NOAEL for SeMet
in rainbow trout varying from 0.006–0.013mg kg dw−1 day−1 (Vidal
et al. 2005; Knight et al. 2016) and 0.07–0.13mg kg bw−1 day−1 for
selenite (Hilton et al. 1980; Rider et al. 2009). In addition to variation
between studies, the use of analysis of variance (ANOVA) type of
analysis within a trial leaves uncertainty as to where the toxicity
threshold lies between the NOAEL and LOAEL, or even lower than the
NOAEL. For example, an earlier dietary SeMet (as Se-yeast) dose-re-
sponse study with juvenile splittail (Pogonichthys macrolepidotus) that
established a NOAEL-LOAEL of respectively 2.7–6.6 mg kg−1 dw (Teh
et al. 2004), was re-analysed by using a logistic regression to derive an
effective concentration of 10% (EC10), giving a new threshold adverse
effect level of 0.9 mg kg−1 dw feed (Rigby et al. 2010).
In establishing safe dietary limits, not only the threshold levels of
toxicity is of importance but also the dietary levels that give no toxic
effect. The introduction of the lower bound bench mark dose (BMDL)
allows establishing of a safe limit based on a common assessment of
different dose-response models fits that are associated with a specific
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change in response (the bench mark response; BMR) (EFSA 2017b). The
lower bound bench mark dose (BMDL) gives the lower 90% variance of
the dose-response model fit, which is defined as the dose that is not
giving an adverse effect and is hence an alternative to NOAEL (EFSA
2017b). As the biomarkers of adverse effect or exposure are early
warning for toxic mode of actions that lead to later adverse effects, it
could be argued that a larger change in response may be chosen to set
safe limits compared to using adverse effects. As the threshold levels of
toxicity strongly depend on exposure duration (Teh et al. 2004) and
most chronic trial only cover 10% of a life cycle (3 months), the use of
early biological markers of selenite or SeMet toxicity is useful.
In the present study, for dietary selenite the best dose-response
model fits (lowest BMDL and BMDU variation and AIC) with the lowest
BMDL were assessed for plasma ALAT, liver vitamin E and histo-
pathology, giving a safe dietary dose of 1–2mg kg−1 ww (dose
0.01–0.02mg kg bw−1 day−1) of total Se for selenite supplementation.
However, the loss of two dose groups due to mortality and the sig-
nificant reduction of GSH and GSSG at the lowest exposure level war-
rants dose-response studies in Atlantic salmon in the range of
0.5–5mg kg−1 ww to assess more accurately the safe limit in Atlantic
salmon with regards to animal health. For dietary SeMet a more ac-
curate BMDL dose-response assessment could be made giving lowest
BMDL for safe animal health limits of 2.8mg kg−1 ww (dose 0.03mg kg
bw−1 day−1) based on liver histopathology, spleen somatic index, and
plasma creatinine model fits. The present study confirmed a higher
relative toxicity for selenite than for SeMet and the safe limits are in the
same range as the earlier reviewed general non effect levels for total
selenium of< 2–3mg kg−1 dw in fish (Lemly 1993a; Hamilton 2004).
In conclusion, feed levels of 1–2mg kg−1 (0.11–0.21mg kg−1 bw
day−1) and 2.8 mg kg−1 (0.29mg kg−1 bw day−1) total Se for respec-
tively selenite and SeMet supplementation to a low fish meal (10%)
based diets with background levels of 0.45mg kg−1, were safe with
regards to fish health. SeMet is known to accumulate in the muscle
(Berntssen et al. 2017), and as food safety is part of the dietary Se limit
assessment, further studies are warranted on the feed-to-fillet transfer
of dietary Se supplementation to assess food safety.
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